SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 190.43-0.7%Feb 6 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (7605)9/25/1997 11:19:00 AM
From: Henry Niman   of 32384
 
Andy, It's in LGND's interest to get the price up for the month of October and there is no reason to sit on clinicals. They have ALRT1550 going into Phase 2b for several cancers (clinical data "better than we could have hoped for"), Targretin Phase II diabetes, new indications for Panretin, Topical Panretrin phase II for psoriasis, start of Topical Phase III for psoriasis, US pivotal Phase III Topical Panretin for KS, Oral Targretin Phase II/III for lung cancer. The wires will be red hot!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext